BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21144983)

  • 1. Pharmacokinetics and pharmacodynamics: optimal antimicrobial therapy in the intensive care unit.
    Lodise TP; Drusano GL
    Crit Care Clin; 2011 Jan; 27(1):1-18. PubMed ID: 21144983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bench-to-bedside review: antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit.
    Kollef MH
    Crit Care; 2005 Oct; 9(5):459-64. PubMed ID: 16277734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial dosage in intensive-care-unit patients based on pharmacokinetic/pharmacodynamic principles.
    Soy D; Torres A
    Curr Opin Crit Care; 2006 Oct; 12(5):477-82. PubMed ID: 16943729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of antimicrobial drugs in intensive care unit patients.
    Macedo RS; Onita JH; Wille MP; Furtado GH
    Shock; 2013 May; 39 Suppl 1():24-8. PubMed ID: 23481498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic stewardship in the intensive care unit.
    Arnold HM; Micek ST; Skrupky LP; Kollef MH
    Semin Respir Crit Care Med; 2011 Apr; 32(2):215-27. PubMed ID: 21506058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug interactions of antimicrobial agents in children with cancer].
    Langebrake C; Uhlenbrock S; Ritter J; Groll AH
    Klin Padiatr; 2005 Nov; 217 Suppl 1():S165-74. PubMed ID: 16288362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of pharmacokinetics and pharmacodynamics of antimicrobial agents.
    Estes L
    Mayo Clin Proc; 1998 Nov; 73(11):1114-22. PubMed ID: 9818049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some current issues in the pharmacokinetics/pharmacodynamics of antimicrobials in intensive care.
    Petrosillo N; Drapeau CM; Agrafiotis M; Falagas ME
    Minerva Anestesiol; 2010 Jul; 76(7):509-24. PubMed ID: 20613692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity and pharmacodynamics of commonly used antibiotics against adult systemic isolates of Escherichia coli and Pseudomonas aeruginosa at Forty US Hospitals.
    Eagye KJ; Kuti JL; Sutherland CA; Christensen H; Nicolau DP
    Clin Ther; 2009 Nov; 31(11):2678-88. PubMed ID: 20110010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to optimise antimicrobial prescriptions in the Intensive Care Unit: principles of individualised dosing using pharmacokinetics and pharmacodynamics.
    Roberts JA; Joynt GM; Choi GY; Gomersall CD; Lipman J
    Int J Antimicrob Agents; 2012 Mar; 39(3):187-92. PubMed ID: 22226651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing antimicrobial resistance in intensive care units.
    Gandhi TN; DePestel DD; Collins CD; Nagel J; Washer LL
    Crit Care Med; 2010 Aug; 38(8 Suppl):S315-23. PubMed ID: 20647789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of antimicrobial therapy in intensive care units.
    Textoris J; Wiramus S; Martin C; Leone M
    Expert Rev Anti Infect Ther; 2011 Jan; 9(1):97-109. PubMed ID: 21171881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial stewardship and the role of pharmacokinetics-pharmacodynamics in the modern antibiotic era.
    Owens RC; Ambrose PG
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3 Suppl):77S-83S. PubMed ID: 17292579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 2002-2006 OPTAMA programs for US hospitals: focus on gram-negative resistance.
    Crandon JL; Kuti JL; Jones RN; Nicolau DP
    Ann Pharmacother; 2009 Feb; 43(2):220-7. PubMed ID: 19193582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New antimicrobial agents for use in the intensive care unit.
    Ritchie DJ; Alexander BT; Finnegan PM
    Infect Dis Clin North Am; 2009 Sep; 23(3):665-81. PubMed ID: 19665089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminoglycosides in the intensive care unit: an old drug in a dynamic environment.
    Miyagawa CI
    New Horiz; 1993 May; 1(2):172-80. PubMed ID: 7922400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Can one use probabilistic protocols for antibiotic therapy in intensive care units?].
    Bourdain N; Lepape A; Galzot F; Lamy B; Haessler D; Chomarat M; Grozel JM; Banssillon V
    Pathol Biol (Paris); 1999 May; 47(5):584-8. PubMed ID: 10418047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of appropriate antimicrobial dosing: pharmacokinetic and pharmacodynamic considerations.
    Preston SL
    Ann Pharmacother; 2004 Sep; 38(9 Suppl):S14-8. PubMed ID: 15226489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit?
    Kollef MH
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S82-8. PubMed ID: 16894520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.